Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression.
Saved in:
| Title: | Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression. |
|---|---|
| Authors: | Ma T; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA., Jin L; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA., Bai S; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Liu Z; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Wang S; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Urological Department, Peking University Cancer Hospital & Institute, Beijing, China., Shen B; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, Hubei, China., Cho Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA., Cao S; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Sun MJS; Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA., Fazli L; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Zhang D; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Duke University, Durham, NC, USA., Wedderburn C; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Zhang DY; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; University of Southern California, Los Angeles, CA, USA., Mugon G; Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA., Ungerleider N; Department of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Baddoo M; Department of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Zhang K; Department of Computer Science, Bioinformatics Facility of Xavier RCMI Center of Cancer Research, Xavier University of Louisiana, New Orleans, LA, USA., Schiavone LH; Discovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden., Burkhardt BR; Department of Cell Biology, Microbiology and Molecular Biology, University of South Florida, Tampa, FL, USA., Fan J; Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA., You Z; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA., Flemington EK; Department of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA., Dong X; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Dong Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.; Southeast Louisiana Veterans Health Care System, New Orleans, LA, USA. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Mar 07; Vol. 116 (3), pp. 421-433. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djad215 |
